Valiant Organics Ltd
Valiant Organics Ltd (VALIANTORG) last reported results for the quarter ended Jun 2026, with sales of ₹232 crore and net profit of ₹29 crore. The stock last traded at ₹488, a market capitalisation of ₹1,367 crore, on a P/E of 27.1. Over the past 52 weeks the stock has ranged between ₹195 and ₹503. Figures are as of 6 Oct 2026 and are not real time.
Valiant Organics Ltd share price and key metrics
- Current price
- ₹488
- Market cap
- ₹1,367 cr
- Stock P/E
- 27.1
- Book value
- ₹271
- ROE
- 3.50%
- ROCE
- 5.47%
- Dividend yield
- 0.00%
- 52w high / low
- 503/195
Metrics as of 6 Oct 2026. Not real time.
Track Valiant Organics Ltd
Cruxal reads every Valiant Organics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Valiant Organics Ltd growth and returns
- 10 Years
- %
- 5 Years
- 0%
- 3 Years
- -11%
- TTM
- 1%
- 10 Years
- %
- 5 Years
- -26%
- 3 Years
- -33%
- TTM
- 895%
- 10 Years
- %
- 5 Years
- -21%
- 3 Years
- 0%
- 1 Year
- 43%
- 10 Years
- %
- 5 Years
- 6%
- 3 Years
- 1%
- Last Year
- 4%
Valiant Organics Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹232 cr, up 13.7% from ₹204 cr a year earlier. Net profit was ₹29 cr, up 262.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 160 | 187 | 204 | 204 | 157 | 159 | 218 | 232 |
| Expenses | 159 | 172 | 183 | 180 | 136 | 146 | 191 | 190 |
| Operating profit | 1 | 15 | 21 | 25 | 21 | 13 | 26 | 42 |
| OPM % | 0.5% | 8% | 10% | 12% | 13% | 8% | 12% | 18% |
| Other income | 3 | 6 | 1 | 2 | 0 | 7 | 5 | 11 |
| Interest | 8 | 6 | 5 | 6 | 4 | 5 | 3 | 5 |
| Depreciation | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 |
| Profit before tax | -14 | 6 | 7 | 11 | 7 | 6 | 18 | 37 |
| Tax % | -9% | 14% | 43% | 26% | 24% | 38% | 10% | 20% |
| Net profit | -12 | 5 | 4 | 8 | 6 | 4 | 16 | 29 |
| EPS (₹) | -4.63 | 1.98 | 1.50 | 2.93 | 2.02 | 1.30 | 5.61 | 10.36 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Valiant Organics Ltd annual results
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 692 | 675 | 755 | 1,153 | 1,052 | 723 | 719 | 739 | 766 |
| Operating profit | 181 | 181 | 205 | 205 | 164 | 37 | 53 | 87 | 102 |
| OPM % | 26% | 27% | 27% | 18% | 16% | 5% | 7% | 12% | 13% |
| Net profit | 121 | 126 | 131 | 128 | 103 | -8 | -3 | 33 | 54 |
| EPS (₹) | 103.65 | 51.00 | 42.19 | 41.72 | 32.45 | -3.04 | -1.34 | 11.86 | 19.29 |
TTM is the trailing twelve months to the most recent quarter.
Valiant Organics Ltd balance sheet
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 6 | 12 | 27 | 27 | 27 | 28 | 28 | 28 |
| Reserves | 254 | 374 | 475 | 586 | 662 | 702 | 697 | 731 |
| Borrowings | 77 | 140 | 209 | 364 | 274 | 257 | 249 | 256 |
| Other liabilities | 112 | 143 | 165 | 216 | 276 | 262 | 209 | 217 |
| Total liabilities | 448 | 669 | 876 | 1,192 | 1,239 | 1,248 | 1,183 | 1,232 |
| Fixed assets | 150 | 276 | 510 | 543 | 670 | 643 | 657 | 695 |
| CWIP | 66 | 129 | 46 | 112 | 71 | 86 | 66 | 21 |
| Investments | 12 | 23 | 6 | 8 | 41 | 99 | 94 | 151 |
| Other assets | 221 | 241 | 314 | 529 | 457 | 420 | 367 | 365 |
| Total assets | 448 | 669 | 876 | 1,192 | 1,239 | 1,248 | 1,183 | 1,232 |
As reported by the company. Total assets equal total liabilities by construction.
Valiant Organics Ltd cash flow
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 76 | 161 | 113 | -31 | 238 | 84 | 56 | 92 |
| Cash from investing | -86 | -184 | -156 | -124 | -143 | -65 | -21 | -86 |
| Cash from financing | 1 | 27 | 49 | 167 | -112 | -23 | -32 | -11 |
| Net cash flow | -9 | 5 | 5 | 12 | -17 | -4 | 4 | -5 |
| Free cash flow | -13 | -44 | -58 | -153 | 108 | 19 | 27 | 59 |
| CFO / operating profit | 68% | 112% | 78% | 6% | 162% | 238% | 106% | 103% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Valiant Organics Ltd operating ratios
| Per year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 39% | 30% | 21% | 14% | 1% | 3% | 5% |
| Debtor days | 75 | 72 | 76 | 102 | 88 | 106 | 90 | 120 |
| Inventory days | 44 | 42 | 63 | 54 | 68 | 88 | 71 | 77 |
| Days payable | 69 | 82 | 93 | 63 | 89 | 159 | 119 | 102 |
| Cash conversion cycle | 50 | 32 | 45 | 93 | 67 | 34 | 42 | 96 |
| Working capital days | 46 | 20 | -1 | 21 | 11 | -3 | -10 | 0 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Valiant Organics Ltd shareholding pattern
Promoters held 37.87% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.21% and DIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 37.77% | 37.73% | 37.91% | 37.91% | 37.91% | 37.89% | 37.89% | 37.87% |
| FIIs | 1.34% | 0.82% | 0.37% | 0.21% | 0.21% | 0.22% | 0.28% | 0.21% |
| DIIs | 0.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 60.80% | 61.44% | 61.72% | 61.87% | 61.86% | 61.89% | 61.82% | 61.93% |
| No. of shareholders | 48,189 | 49,017 | 48,077 | 44,293 | 43,274 | 42,311 | 40,928 | 40,526 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Valiant Organics Ltd corporate filings
- Please find our intimation in captioned subjectCompany Updatelow impact
- Valiant Organics Receives Rs. 22.15 Lakh Income Tax Rectification Order Pertaining to AY 2015-16, Highlighting Past Tax DisputesCompany Updatelow impact
Cruxal's analysis: Valiant Organics Limited has received a Rectification Order dated July 8, 2026, from the…
Read the full analysis - Valiant Organics Approves Management Reappointments and MD Term Extension at AGM, No Immediate Financial ImpactCompany Updatelow impact
Cruxal's analysis: Valiant Organics Limited announced at its 21st AGM held on September 29, 2026, the…
Read the full analysis - Valiant Organics Announces Board Approvals for Strategic Related Party Transactions and Board Resolutions, Indicating Active Governance and Strategic AlignmentAGM/EGMhigh impact
Cruxal's analysis: Valiant Organics has received shareholder approval for multiple related party…
Read the full analysis - Announcement under Regulation 30 (LODR)-Investor PresentationCompany Updatemedium impact
- Shareholder Meeting / Postal Ballot-Outcome of AGMAGM/EGMmedium impact
- Please find our intimation in the captioned subjectInsider Trading / SASTlow impact
- Valiant Organics Limited Announces 21st Annual General Meeting for September 29, 2026Company Updatelow impact
Cruxal's analysis: Valiant Organics Limited has issued a formal notice for its 21st Annual General Meeting…
Read the full analysis - Valiant Organics Ltd files Business Responsibility and Sustainability Report for FY 2025-26Otherslow impact
Cruxal's analysis: Valiant Organics Ltd has submitted its Business Responsibility and Sustainability Report…
Read the full analysis - Valiant Organics Limited Announces 21st AGM and FY 2025-26 Annual ReportAGM/EGMhigh impact
Cruxal's analysis: Valiant Organics Limited has scheduled its 21st Annual General Meeting for September 29…
Read the full analysis - Valiant Organics Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Valiant Organics Ltd has filed its Annual Report for the financial year 2025-26. This is…
Read the full analysis - Valiant Organics Ltd announces newspaper publication for 21st Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Valiant Organics Ltd has completed the mandatory newspaper publication regarding the…
Read the full analysis - Valiant Organics Reports Strong Q1-FY27 Recovery with 14% YoY Revenue Growth and Significant Margin ExpansionCompany Updatehigh impact
Cruxal's analysis: Valiant Organics Limited has demonstrated a robust financial turnaround in Q1-FY27…
Read the full analysis - Valiant Organics Limited Announces Q1 FY2027 Financial Results and IEPF Dividend Transfer NoticeCompany Updatelow impact
Cruxal's analysis: Valiant Organics Limited has released its unaudited standalone and consolidated financial…
Read the full analysis - Valiant Organics Ltd: Routine Newspaper Publication of Financial ResultsCompany Updatelow impact
Cruxal's analysis: Valiant Organics Ltd has fulfilled its regulatory obligation under Regulation 30 of the…
Read the full analysis - Valiant Organics Ltd announces grant of stock options under existing ESOP schemeCompany Updatelow impact
Cruxal's analysis: Valiant Organics Ltd has issued an intimation regarding the grant of stock options to…
Read the full analysis - Valiant Organics Ltd announces change in corporate office addressCompany Updatelow impact
Cruxal's analysis: Valiant Organics Ltd has filed an intimation regarding a change in its corporate office…
Read the full analysis - Valiant Organics Reports Strong Q1 FY27 Financials with Significant Profit Growth and Segment TurnaroundBoard Meetinghigh impact
Cruxal's analysis: Valiant Organics Limited reported a robust performance for the quarter ended June 30…
Read the full analysis - Valiant Organics Limited schedules Board Meeting for August 12, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Valiant Organics Limited has formally intimated the stock exchanges regarding a Board…
Read the full analysis - Valiant Organics Limited Credit Outlook Upgraded to 'Stable' by CRISILCompany Updatehigh impact
Cruxal's analysis: Valiant Organics Limited has received a positive credit rating action from CRISIL, which…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.